Puri, Raman <br/><br/>
Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India.  [electronic resource] 

 -  Journal of clinical lipidology   
 - e1-e13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1933-2874 
<br/><br/><label>Standard No.: </label>10.1016/j.jacl.2020.01.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Cholesterol, LDL--blood<br/>Clinical Trials as Topic<br/>Consensus<br/>Goals<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Hyperlipoproteinemia Type II--blood<br/>India<br/>Lipoprotein(a)--blood<br/>Mutation<br/>Practice Guidelines as Topic<br/>Proprotein Convertase 9--genetics<br/>Secondary Prevention--methods<br/>Social Control, Formal<br/>Societies, Medical<br/>Triglycerides--blood